Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Mupirocin Calcium

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,244Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal's Generic Mupirocin Calcium Receives Approval in the U.S.
    Amneal's Generic Mupirocin Calcium Receives Approval in the U.S.

    15 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214811

    FDA
    15 Nov 2022
    Share Share
    Padagis Generic Mupirocin Calcium Receives Approval in the U.S.
    Padagis Generic Mupirocin Calcium Receives Approval in the U.S.

    03 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212465

    FDA
    03 Aug 2022
    Share Share
    Aleor Dermaceutical`s Generic Metronidazole Receives Approval in the US
    Aleor Dermaceutical`s Generic Metronidazole Receives Approval in the US

    19 Nov 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213053

    FDA
    19 Nov 2021
    Share Share
    GlaxoSmithKline recalls Bactroban (mupirocin calcium) Nasal Ointment, 2% due to Cross Contamination
    GlaxoSmithKline recalls Bactroban (mupirocin calcium) Nasal Ointment, 2% due to Cross Contamination

    05 Sep 2015

    // FDA

    http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-1359-2015&w=09022015&lang=eng

    FDA
    05 Sep 2015
    Share Share